Current and historical daily PE Ratio for Pharmicell Co Ltd (
XKRX:005690
) from 1990 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Pharmicell stock (XKRX:005690) PE ratio as of Apr 25 2024 is 95.01.
More Details
Pharmicell Co Ltd (XKRX:005690) PE Ratio (TTM) Chart
Pharmicell Co Ltd (XKRX:005690) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1241
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Pharmicell PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-25 | 95.0 | 2024-02-20 | 94.7 |
| 2024-04-24 | 95.0 | 2024-02-19 | 94.7 |
| 2024-04-23 | 95.0 | 2024-02-16 | 92.9 |
| 2024-04-22 | 93.2 | 2024-02-15 | 93.2 |
| 2024-04-19 | 91.2 | 2024-02-14 | 93.7 |
| 2024-04-18 | 94.0 | 2024-02-13 | 94.2 |
| 2024-04-17 | 91.2 | 2024-02-08 | 93.4 |
| 2024-04-16 | 88.8 | 2024-02-07 | 93.4 |
| 2024-04-15 | 90.6 | 2024-02-06 | 94.7 |
| 2024-04-12 | 93.5 | 2024-02-05 | 95.2 |
| 2024-04-11 | 91.5 | 2024-02-02 | 95.3 |
| 2024-04-09 | 91.7 | 2024-02-01 | 93.7 |
| 2024-04-08 | 91.7 | 2024-01-31 | 93.8 |
| 2024-04-05 | 93.0 | 2024-01-30 | 94.5 |
| 2024-04-04 | 95.0 | 2024-01-29 | 94.7 |
| 2024-04-03 | 96.5 | 2024-01-26 | 93.4 |
| 2024-04-02 | 99.1 | 2024-01-25 | 92.0 |
| 2024-04-01 | 105.8 | 2024-01-24 | 93.2 |
| 2024-03-29 | 102.7 | 2024-01-23 | 96.2 |
| 2024-03-28 | 102.7 | 2024-01-22 | 93.8 |
| 2024-03-27 | 105.4 | 2024-01-19 | 93.5 |
| 2024-03-26 | 110.3 | 2024-01-18 | 94.3 |
| 2024-03-25 | 109.8 | 2024-01-17 | 95.2 |
| 2024-03-22 | 107.7 | 2024-01-16 | 99.4 |
| 2024-03-21 | 110.6 | 2024-01-15 | 100.6 |
| 2024-03-20 | 110.5 | 2024-01-12 | 100.1 |
| 2024-03-19 | 105.8 | 2024-01-11 | 102.4 |
| 2024-03-18 | 107.5 | 2024-01-10 | 100.6 |
| 2024-03-15 | 96.8 | 2024-01-09 | 103.5 |
| 2024-03-14 | 100.6 | 2024-01-08 | 98.8 |
| 2024-03-13 | 102.9 | 2024-01-05 | 99.8 |
| 2024-03-12 | 101.7 | 2024-01-04 | 101.9 |
| 2024-03-11 | 101.7 | 2024-01-03 | 105.2 |
| 2024-03-08 | 92.9 | 2024-01-02 | 102.4 |
| 2024-03-07 | 88.8 | 2023-12-28 | 99.8 |
| 2024-03-06 | 90.7 | 2023-12-27 | 107.4 |
| 2024-03-05 | 88.4 | 2023-12-26 | 104.5 |
| 2024-03-04 | 89.6 | 2023-12-22 | 104.8 |
| 2024-02-29 | 88.8 | 2023-12-21 | 105.0 |
| 2024-02-28 | 89.9 | 2023-12-20 | 103.0 |
| 2024-02-27 | 89.4 | 2023-12-19 | 103.6 |
| 2024-02-26 | 91.1 | 2023-12-18 | 102.5 |
| 2024-02-23 | 93.4 | 2023-12-15 | 101.2 |
| 2024-02-22 | 93.5 | 2023-12-14 | 97.4 |
| 2024-02-21 | 93.7 | 2023-12-13 | 96.8 |
Pharmicell Co Ltd (XKRX:005690) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Pharmicell Co Ltd
ISIN : KR7005690003
Share Class Description:
XKRX:005690: Ordinary SharesCompare
Compare
Traded in other countries / regions
005690.Korea IPO Date
1988-05-20Description
Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers